Growth Metrics

Kyverna Therapeutics (KYTX) Amortizatization of Intangibles (2023 - 2026)

Kyverna Therapeutics posted quarterly Amortizatization of Intangibles of $730000.0 for Q1 2026, down 65.4% year-on-year from $2.1 million in Q1 2025, and down 46.64% on a QoQ basis from $1.4 million in Q4 2025.

Kyverna Therapeutics (KYTX) has 4 years of Amortizatization of Intangibles data on file, last reported at $730000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Amortizatization of Intangibles fell 65.4% year-over-year to $730000.0; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (down 41.98% YoY), and the FY2025 full-year result was $6.9 million, down 10.13% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $730000.0, down from $1.4 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.9 million in Q3 2024 and bottomed at -$8000.0 in Q2 2023.
  • The 4-year median for Amortizatization of Intangibles is $1.4 million (2025), against an average of $1.3 million.
  • The widest annual swing landed in 2024, when Amortizatization of Intangibles jumped 28287.5%; it then slumped 65.4% in 2026.
  • A 4-year view of Amortizatization of Intangibles shows it stood at $605000.0 in 2023, then surged by 269.59% to $2.2 million in 2024, then sank by 38.82% to $1.4 million in 2025, then tumbled by 46.64% to $730000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $730000.0 (Q1 2026), $1.4 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 13,267.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Kyverna Therapeutics 497.98 Mn 265.03 Mn - 730,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 730,000.00
Mar 31, 2026 730,000.00
Dec 31, 2025 1.37 Mn
Dec 31, 2025 1.37 Mn
Sep 30, 2025 1.57 Mn
Sep 30, 2025 1.57 Mn
Jun 30, 2025 1.84 Mn
Jun 30, 2025 1.84 Mn
Mar 31, 2025 2.11 Mn
Mar 31, 2025 2.11 Mn
Dec 31, 2024 2.24 Mn
Dec 31, 2024 2.24 Mn
Sep 30, 2024 2.89 Mn
Sep 30, 2024 2.89 Mn
Jun 30, 2024 2.26 Mn
Jun 30, 2024 2.26 Mn
Mar 31, 2024 280,000.00
Mar 31, 2024 280,000.00
Dec 31, 2023 605,000.00
Dec 31, 2023 605,000.00
Sep 30, 2023 440,000.00
Sep 30, 2023 440,000.00
Jun 30, 2023 -8,000.00
Jun 30, 2023 -8,000.00
Mar 31, 2023 78,000.00
Mar 31, 2023 78,000.00